Inscape Announces the Financial Results for Fourth Quarter and Full Year 2020
Inscape (INQ), a company designs and manufactures the furnishings for the workplace, has reported its results of operations for the…
Erdene Releases the Results of Annual and Special Meeting of Shareholders
Erdene Resource Development Corporation, a Canada-based resource company held an Annual and Special Meeting of Shareholders on June 25, 2020…
Albertsons Companies Announces the Pricing of Initial Public Offering, trading to begin today on NYSE
Albertsons Companies, Inc. has priced its initial public offering of 50 million shares of its common stock at $16.00 per…
Acreage Holdings Announces the Results for First Quarter of FY 2020
Acreage Holdings, Inc. announced the financial results for the first quarter of 2020 with a substantial increase in revenue. Acreage…
American Bible Society Appoints New President And CEO
American Bible Society has announced that the company has appointed Robert Briggs as the President and Chief Executive Officer of…
MIB Collaborates With Utah Health Information Network To Streamline Electronic Health Records
MIB has announced that the company has collaborated with the Utah Health Information Network (UHIN) to streamline and innovate the…
Novavax Agrees to Raise $200 Million from a Private Placement with RA Capital Management
Novavax, Inc., a late-stage biotechnology company initiated the development of a vaccine against the virus that causes COVID-19, announced that…
OREGE releases Annual Results of year 2019 & provides activity update
OREGE has released its annual results for the year 2019 and also provided an update on its activities. The company…
Water Ways Declares Financial Results for First Quarter 2020 with Record Quarterly Sales
Water Ways Technologies Inc. has announced its results of its financial and business operations for first quarter ended March 31,…
Esperion Announces pooled analysis results from four Phase 3 clinical studies of NEXLETOL that presented at the American Diabetes Association 80th Scientific Sessions
Esperion (ESPR) announced that it had presented pooled analysis from four Phase 3 clinical studies of NEXLETOL at the American…